PMI 07
Alternative Names: PMI-07Latest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator Precision Molecular
- Class Diagnostic agents; Imaging agents
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Fibrosis
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for preclinical development in Cancer in USA
- 28 Nov 2024 No recent reports of development identified for preclinical development in Fibrosis in USA
- 21 Oct 2020 Preclinical trials in Cancer in USA (unspecified route) (D and D Pharmatech pipeline, October 2020)